#Sartorius Stem Cell Banking Market

[healthcarehubhh]

Cell Culture Market to Reach US$19,198.0 Million by 2024 Owing to Growing R&D Investments in Pharmaceutical Industry

The cell culture market has emerged as an important subject area in the fields of biotechnology and pharmaceutical industry. Cell culture involves growing eukaryotic or prokaryotic cells in an artificial controlled environment with a special growth medium. These cells can be derived from plants or animals and are allowed to grow, interact, and divide. Cell culture provides an ideal platform for understanding various aspects of cell physiology outside the body and helps in drug development processes. The Global cell culture market is estimated to be valued at US$ 19,198.0 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. These players are focusing on new product launches and expansions to strengthen their market position. For instance, in 2021, Merck launched new cell culture media to support cell therapy research and developments. The demand for cell culture products is driven by the increasing investments in pharmaceutical and biotech research and rising prevalence of chronic diseases worldwide. Biopharmaceutical companies are engaged in developing novel biologic drugs for the treatment of diseases like cancer, cardiovascular, and infectious diseases which requires extensive cell-based research. Technological advancements like automated cell culture systems, serum-free media, and animal component-free solutions are helping researchers to gain insights faster. Developments in 3D cell culture techniques that can better mimic in vivo environments are further expected to provide a boost to the market. Market Trends Single-use bioreactors : Single-use bioreactors that minimize the risks of contamination and reduce production timelines are being increasingly adopted by biopharma players for monoclonal antibody production and viral vaccine manufacturing. Stem cell banking: Established companies are entering stem cell banking to facilitate clinical research in regenerative medicine. Increasing stem cell therapy treatments will drive the demand for reliable stem cell banking solutions. Market Opportunities Personalized medicine: Advancements in genomic sequencing technologies are enabling the development of novel personalized therapy approaches. This will open opportunities for developing patient-specific induced pluripotent stem (iPS) cell lines. Developing markets: Emerging economies in Asia Pacific and Latin America are witnessing significant growth in biotech industry. Leading players can expand their presence in these regions to tap into the opportunity.

[poojascmi]

Cell Processing Market 2022-2028 Innovations: Pioneering Breakthroughs in Biotechnology

The Cell Processing Market is currently experiencing a revolutionary phase, marked by a plethora of innovative breakthroughs in the field of biotechnology. These pioneering advancements are reshaping the landscape of healthcare and opening new avenues for personalized medicine, regenerative therapies, and disease treatment. This Report delves into some of the remarkable innovations that are propelling the Cell Processing Market to the forefront of modern medicine.

One of the most noteworthy innovations within the Cell Processing Market is the development of automated and integrated cell processing platforms. These platforms streamline and optimize the complex process of isolating, culturing, and manipulating cells. Through automation, researchers and clinicians can maintain high levels of precision, reduce contamination risks, and enhance the reproducibility of results. This not only accelerates research and development but also plays a crucial role in the large-scale production of cell-based therapies.

Furthermore, advancements in gene editing techniques, particularly CRISPR-Cas9, have revolutionized the way cells are modified for therapeutic purposes. Researchers can now precisely engineer cells to correct genetic mutations, modulate gene expression, or introduce therapeutic genes. This has led to the development of novel cell therapies that hold immense promise for treating genetic disorders, cancer, and autoimmune diseases.

The primary constraining factors affecting the Cell Processing Market revenue include patient safety concerns and cell commercialization. It also addresses safety concerns for cell preservation and delivery, as well as tailored cell therapies for patients. Failures of stem cell therapy studies due to strict laws and regulations also impede the expansion of the cell processing sector.

In the context of stem cell therapies, induced pluripotent stem cells (iPSCs) have emerged as a groundbreaking innovation. iPSCs are derived from a patient's own cells and can be differentiated into various cell types for transplantation. This personalized approach circumvents issues related to immune rejection and ethical concerns associated with embryonic stem cells. As a result, iPSCs have paved the way for patient-specific regenerative treatments, ranging from heart tissue regeneration to neural repair.

Moreover, the integration of artificial intelligence (AI) and machine learning (ML) has significantly augmented cell processing techniques. AI-driven algorithms can analyze vast amounts of data generated during cell processing, enabling real-time monitoring of cell quality, viability, and behavior. This not only enhances the quality of cell therapies but also accelerates the decision-making process in research and clinical settings.

Due to the increasing number of cell banks in economies such as China, India, Singapore, and Malaysia, the Asia Pacific Cell Processing Market revenue is predicted to expand significantly throughout the forecast period. Cordlife, a Singapore-based company, operates Singapore's largest cord blood bank and is the first in Southeast Asia to receive dual accreditation from the American Association of Blood Banks (AABB) and the Foundation for the Accreditation of Cellular Therapy (FACT).

Top Companies involved are Beckman Coulter, Inc. (subsidiary of Danaher Corporation), Becton, Dickinson and Company, GE Healthcare, Lonza Group, Merck KGaA, Miltenyi Biotec, Sartorius AG, Stemcell Technologies, Terumo Bct, Inc. (subsidiary of Terumo Corporation), Thermo Fisher Scientific Inc., Cesca Therapeutics, Biosafe, Cryo-Cell, and Americord.

[rohans18]

Thawing Equipment Market Trends, Share, Competitive Dynamics, Demand - Forecast 2029

Global Thawing Equipment Market, By Product (Manual, Automatic), Sample (Blood Products, Ovum/Embryo, Semen, Human Tissue Samples, Organs, Stem Cells, Other), End User (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories, Pharmaceutical Industry, Biobanks, Gene Banks), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications) – Industry Trends and Forecast to 2029.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Thawing Equipment marketing report. The report has a lot to offer to both established and new players in the Thawing Equipment industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Thawing Equipment market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Thermo Fisher Scientific Inc. (U.S.)

Merck KGaA (Germany)

ThermoGenesis Holdings Inc. (U.S.)

BioLifeSolutions (U.S.)

So-Low Environmental Equipment Co. (U.S.)

Helmer Scientific Inc. (U.S.)

OPS Diagnostics LLC (U.S.)

Sartorius AG (Germany)

Sarstedt AG & Co. KG (Germany)

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-thawing-equipment-market

With the help of credible Thawing Equipment market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Thawing Equipment market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Thawing Equipment Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[healthcare-domain]

The Future of Cell Expansion Market

According to the new market research report "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025", published by MarketsandMarkets™, the Cell Expansion Market is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

Growth in this market is primarily driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.

The media segment accounted for the largest share of the consumables segment in the Cell Expansion Market Based on product type, consumables are segmented into media, reagents, sera, and disposables. The media segment accounted for the largest share of the consumables segment in the market. The large share of this segment can be attributed to its high requirement during the production of pharmaceutical products and rising R&D investments on cell-based therapies.

Browse in-depth TOC on "Cell Expansion Market"

595 – Tables 33 – Figures   354 – Pages

Biotechnology & biopharmaceutical companies accounted for the fastest-growing end user segment of the market

Based on end-users, the market has been segmented into research institutes, biotechnology & biopharmaceutical companies, cell banks, and other end users (includes hospitals, diagnostic centers, and laboratories). In 2019, biotechnology & biopharmaceutical companies were the largest end-users in the Cell Expansion Market, and the trend is the same throughout the forecast period. Increasing production of regenerative medicine and rising awareness regarding advanced treatment methods such as personalized medicines and other cell-based therapies are the major driving factors for this segment.

North America accounted for the largest share of the market

North America accounted for the largest share of the market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, increasing geriatric population, and the strong presence of industry players in the region.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883

Some of the leading players in the Cell Expansion Market include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany)

Growth in this market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and growing GMP certifications for cell therapy production facilities.  

For More Info @ https://www.prnewswire.com/news-releases/cell-expansion-market-worth-30-1-billion-by-2025--exclusive-report-by-marketsandmarkets-301088259.html

[reportcrux]

Asia Pacific Single-Cell Analysis Market Size, Trends and Forecast to 2027

Asia Pacific Single-Cell Analysis Market 2021 Report delivers in-depth data on market size, growth rate, share at country, region and segments level to frame strategic business plans and growth strategies for all business needs. The report is comprehensive blend of quantitative revenue data supported by qualitative data such as growth drivers, opportunities, market challenges, SWOT analysis, PEST analysis along with COVID-19 impact on the businesses across the world.

"Asia Pacific Single-Cell Analysis Market" report offers detailed analysis on specific developments in the market and key business strategies implemented by major market players to strengthen their businesses and market share. The report highlights company profiles, competitive landscape along with product benchmarking analysis for key market players.

Complete analysis on value (revenue),) and growth rate data are provided for years 2016 to 2027. Exhaustive key regional and country level trends and growth drivers are analysed to provide granular market analysis. Report demonstrates historic revenue and growth trends data for years 2016 to 2019 and forecast data for the years 2021 to 2027.

Request a Sample PDF of Report @ https://reportcrux.com/request-sample-report/Single-Cell-Analysis-Market

A thorough analysis on market effect factors, market risks, technological progress, consumer buying behaviour is covered along with value chain analysis, upstream and downstream market development trends and price and cost trends for product and raw materials.

Covid-19 impact analysis

Covid-19 impact analysis focuses on analysing pre- and post-pandemic growth trends, short term and long-term industry dynamics across major regions. Covid-19 recovery path analysis gives insights on the major strategies implemented by industries to respond and recover from the economic crisis due to Covid-19 pandemic. Also, SWOT analysis, PESTEL analysis and Porter's Five forces analysis is clear understanding of market growth influencing factors.

The report offers critical market information crucial for business decisions and strategy implementation based on current market trends and scope. The report also adds strategic inputs gained from key opinion leaders and business decision makers in the related industry.

Key Market Players:

Becton,     Dickinson and Company

Danaher     Corporation

Merck     Millipore

Qiagen     N.V.

Thermo     Fisher Scientific, Inc.

General     Electric Company

10x     Genomics

Promega     Corporation

Illumina,     Inc.

Bio-Rad     Laboratories, Inc.

Fluidigm     Corporation

Agilent     Technologies, Inc.

Nanostring     Technologies, Inc.

Tecan     Group Ltd.

Sartorius     AG

Luminex     Corporation

Takara     Bio Inc.

Fluxion     Biosciences

Menarini     Silicon Biosystems

Lumacyte

Others

The report is prepared by thorough primary and secondary research. Secondary data sources include company websites, magazines, press releases, SEC filings, various paid databases and others. Primary research involves interviews with key industry experts, KOLs, major vendors from both supply and demand side.

Are you Looking for Regional Insights / Report Customization? https://reportcrux.com/request-customization/Single-Cell-Analysis-Market

Asia Pacific Single-Cell Analysis market report is segmented as:

By Application

Research     Applications

Cancer

Immunology

Neurology

Stem     Cell

Other     Research Applications (Tissue Regeneration, Drug Discovery, and Research     on Aging)

Medical     Applications

Noninvasive     Prenatal Diagnosis

in     Vitro Fertilization

Circulating     Tumor Cell Detection

By Technique

Flow     Cytometry

Next-generation     Sequencing

Polymerase     Chain Reaction

Microscopy

Mass     Spectrometry

Other     Techniques (Fluorescence In Situ Hybridization (FISH), Capillary     Electrophoresis (CE), Single-Molecule Fluorescence In Situ Hybridization     (smFISH), and Micromanipulation)

By Cell Type

Human     Cells

Animal     Cells

Microbial     Cells

By Product

Consumables

Beads

Microplates

Reagents

Assay     Kits

Immunoassays

Cell-based     Assays

Other     Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials,     Filtration Apparatus, Petri Dishes, Inserts, and Discs)

Instruments

Flow     Cytometers

NGS     Systems

PCR     Instruments

Spectrophotometers

Microscopes

Cell     Counters

HCS     Systems

Microarrays

Other     Instruments (Laser Capture Microdissection (LCM) Systems,     Micromanipulation Devices, and Integrated Fluidic Circuits (IFCs))

By End User

Academic     & Research Laboratories

Biotechnology     & Pharmaceutical Companies

Hospitals     & Diagnostic Laboratories

Cell     Banks & IVF Centers

The regional scope covers value (revenue) data for below mentioned countries and regions:

North     America (U.S., Canada, Rest of North America)

Europe     (UK, Germany, France, Italy, Spain, Rest of Europe)

Asia     Pacific (China, Japan, India, Southeast Asia, Rest of Asia Pacific)

Latin     America (Brazil, Mexico, Rest of Latin America)

Middle     East and Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and     Africa)

Years considered in the report are:

Historic     Years: 2016-2019

Base     Year: 2019

Estimated     Year: 2020

Forecast     Year 2020 to 2027

Key Advantages to purchase Asia Pacific Single-Cell Analysis Market Report:

To     gain complete analysis on market potential, growth and trends data

To     analyse current competitive trends in the market and strategies used by     key players to strengthen their businesses & leading market position

Evaluate     major market challenges and risks and implement solutions or strategies to     mitigate the market risks

To     gain clear understanding of global market scope, potential, growth     influencing drivers, restraints and opportunities

To     perceive future market outlook and growth prospects for strategic business     decisions like geographic or product portfolio expansion

Besides     syndicate reports, we also offer customized research solutions and     consulting services for specific business needs

Key Highlights of Asia Pacific Single-Cell Analysis Market Report:

Granular     analysis of market size estimates in terms of value (revenue), and growth     rate at country and region level for each segment and sub-segment

Current     industry trends and developments shaping the market

Competitive     market share analysis for major market players, pricing and cost analysis     along with product benchmarking

Qualitative     analysis of growth driving factors, opportunities, restraints, market     challenges and risks or threats

Market     attractiveness analysis for each major segment

To     analyse the revenue pockets in the market for stakeholders or major     vendors by categorizing the specific high growth segments

  Browse Full Report Access here: https://reportcrux.com/summary/7145/Single-Cell-Analysis-Market

[healthcareresearchboom]

Cell Therapy Technologies Market Outlook: Post Covid-19 Scenario by 2025

The cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The emerging economies such as Australia and China are expected to provide a wide range of growth opportunities for players in the market which is driven by their large and growing populations as well as increase in the number of clinical trials and investments in the field of personalized medicine in these countries.

The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, a large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities.

Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978

“Consumables is expected to hold the largest share of the cell therapy technologies market, by product in 2020.”

On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the cell therapy technologies market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

“T-cells is expected to hold the largest share of the cell therapy technologies market, in 2020.”

On the basis of cell type, the market is segmented into T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the cell therapy technologies market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.

“Cell processing is expected to hold the largest share of the cell therapy technologies market in 2020.”

On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

“Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the cell therapy technologies market in 2020.”

By end user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes, and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.

“North America commanded the largest share of the cell therapy technologies market in 2020.”

On the basis of region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the cell therapy technologies market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

The major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany). MaxCyte (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Fresenius Medical Care AG & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), CellGenix GmbH (Germany), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), Hemasoft (US), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Corporation (US).

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

Don’t miss out on business opportunities in Cell Therapy Technologies Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[industrynewshour]

High Density Cell Banking Market Growth Insight, analysis, Future Growth Outlook 2027

Recent report published by research nester titled “Global High Density Cell Banking Market: Global Demand Analysis & Opportunity Outlook 2027”delivers detailed overview of the global high density cell banking market in terms of market segmentation segmented by cell type; by end-user industries and by regions.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The global High density cell banking market is segmented by cell type into human cells, plant cells, animal cells, micro-organisms and others; by end-user industries into pharmaceuticals companies, academic institutes, research centers and biotechnology companies and by regions. High density cell banking market is anticipated to mask a significant CAGR during the forecast period i.e. 2018-2027.

High density (HD) cell banking involves the cell optimization and scaling-up processes. Seed train optimization is high density cell banking that involves larger volume frozen seed banks, elimination of seed steps from vial and allows banking of larger volumes up to 1 liter. Elimination of the intermediary is permitted on use of High Density Cell Banking steps between cryovial thaws to bioreactor and allows seeding directly into the bioreactor. Advantages of this method include the ability to eliminate steps in the seed train process thereby reducing time to bioreactor and consistent inoculation across process runs.

North America dominates the global high density (HD) cell banking market in terms of revenue generation followed by Europe. North America and certain parts of European regions are expected to witness significant growth due to increased adoption of high density (HD) cell banking and due to rising awareness in these regions. Asia-Pacific is expected to witness significant growth as compared to other regions and countries owing to increase in spending in pharmaceutical sector and presence of several biotechnology and research and development institutions.

Get a Sample Report @ https://www.researchnester.com/sample-request-623

Increasing R&D activities

The demand for High Density (HD) Cell Banking is powered by increasing research and development expenditure in medical and biotechnology industry. Rising demand in therapeutic areas for stem cell research like cancer and autoimmune diseases is predicted to enhance demand for high-density cell banking over the forecast period.

However, low awareness about technological advancements and lack of technical expertise in developing and under-developed regions is expected to hamper the growth in terms of revenue of the high-density cell banking market over the forecast period.

Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-623

This report also provides the existing competitive scenario of some of the key players of the global high density cell banking market which includes company profiling of Genzyme Corporation, Pall Corporation, General Electric Company, Sartorius AG, REPLIGEN CORPORATION, Merck Millipore, Thermo Fisher Scientific Inc., Quest International B.V., Qiagen. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global high density cell banking market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.    

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[marketresearchtrendsblog]

Cell Culture Media Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global cell culture media market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global cell culture media market to grow with a CAGR of 8.1% over the forecast period from 2019-2025. The study on cell culture media market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025. The report on cell culture media market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cell culture media market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Get More Information Here: https://www.sdki.jp/sample-request-103964 Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cell culture media market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider. Report Findings 1) Drivers • Increasing research and development activities for biological drug development • Increasing manufacturing of biopharmaceuticals 2) Restraints • High cost of the culture media and their maintenance 3) Opportunities • Increasing funding and new innovations can provide better opportunities to the market in forecast period Research Methodology A) Primary Research Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include 1. Key Opinion Leaders associated with Infinium Global Research 2. Internal and External subject matter experts 3. Professionals and participants from the industry Our primary research respondents typically include 1. Executives working with leading companies in the market under review 2. Product/brand/marketing managers 3. CXO level executives 4. Regional/zonal/ country managers 5. Vice President level executives. B) Secondary Research Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include 1. Company reports and publications 2. Government/institutional publications 3. Trade and associations journals 4. Databases such as WTO, OECD, World Bank, and among others. 5. Websites and publications by research agencies Segment Covered The global cell culture media market is segmented on the basis of product type, application, and end user. The Global Cell Culture Media Market by Product Type • Serum-free Media • Chemically Defined Media • Lysogeny Broth • Classical Media • Stem Cell Media • Specialty Media • Other Product The Global Cell Culture Media Market by Application • Biopharmaceuticals • Biological Drug Discovery • Cancer Research • Tissue Engineering • Stem Cell Technologies • Other Applications The Global Cell Culture Media Market by End User • Academic Institute • Research And Development Laboratory • Biotechnology Industry • Other End User Company Profiles The companies covered in the report include • Becton • Dickinson and Company (BD) • Bio-Rad Laboratories Inc. • GE Healthcare • Merck & Co., Inc. • Thermo Fisher Scientific Inc. • Vitro Diagnostics, Inc. • Avantor Performance Materials • Sartorius AG • HiMedia Laboratories Pvt., Ltd • Other companies What does this report deliver? 1. Comprehensive analysis of the global as well as regional markets of the cell culture media market. 2. Complete coverage of all the segments in the cell culture media market to analyze the trends, developments in the global market and forecast of market size up to 2025. 3. Comprehensive analysis of the companies operating in the global cell culture media market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count Email: sales@sdki.jp Tel: + 81 3 45720790

[itssashasharma]

Cell Therapy Technologies Market worth USD 5.6 billion : Large number of oncology-related cell therapy clinical trials

According to the new market research report “Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) – Global Forecast to 2025″, published by MarketsandMarkets™, the Cell Therapy Technologies Market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.

Browse in-depth TOC on “Cell Therapy Technologies Market”

106 – Tables 41 – Figures 173 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, a large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities.

“Consumables is expected to hold the largest share of the cell therapy technologies market, by product in 2020.”

On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

“T-cells is expected to hold the largest share of the cell therapy technologies market, in 2020.”

On the basis of cell type, the market is segmented into T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.

“Cell processing is expected to hold the largest share of the market in 2020.”

On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

“Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the market in 2020.”

By end user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes, and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.

Request for sample pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978

“North America commanded the largest share of the cell therapy technologies market in 2020.”

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

The major players operating in this cell therapy technologies market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany). MaxCyte (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Fresenius Medical Care AG & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), CellGenix GmbH (Germany), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), Hemasoft (US), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Corporation (US).

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region – Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) – Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-therapy-technologies-market.asp  Visit Our Web Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/cell-therapy-technologies.asp

[marketresearch-articles]

Stem Cell Manufacturing Market trends and outlook 2021-28

The stem cell manufacturing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.1% in the forecast period of 2021 to 2028 and is expected to reach USD 23,505.08 million by 2028 from USD 11,076.78 million in 2020. The rising prevalence of cancer and stem cell transplant, growth of novel technological advancements for stem cell transplant is likely to be the major drivers which propel the demand of the market in the forecast period.

Stem cells are body's raw material that can differentiate into a variety of cells. It means cells from which all other cells with specialized functions are generated. Stem Cell therapies are defined as treatment for a medical condition that involves the use of any type of human stem cells including embryonic stem cells, adult stem cells for allogeneic and autologous therapies.

.

Download Sample Report @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-stem-cell-manufacturing-market

  The major companies providing global stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.

 Get Details TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-minimally-invasive-non-invasive-product-service-market

  Global Stem Cell Manufacturing Market Scope and Market Size

The global stem cell manufacturing market is categorized into four notable segments which are based on products, application, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Based on products, the global stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. In 2021, the consumables & kits segment is expected to dominate the market due to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies

Based on application, the global stem cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking, and others. In 2021, the research applications segment is expected to dominate the market because due to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.

View complete report @ https://www.databridgemarketresearch.com/reports/global-stem-cell-manufacturing-market

 Customization Available: Global Stem Cell Manufacturing Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Browse related report @ Breast Pumps Market 

                                          C-Arms Market

                                          CADASIL treatment market

                                          Candidiasis Therapeutics Market

                                          Cardiac Rehabilitation Market

[rohans18]

Thawing Equipment Market Growth, Analysis, Size and Forecast 2029

Global Thawing Equipment Market, By Product (Manual, Automatic), Sample (Blood Products, Ovum/Embryo, Semen, Human Tissue Samples, Organs, Stem Cells, Other), End User (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories, Pharmaceutical Industry, Biobanks, Gene Banks), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications) – Industry Trends and Forecast to 2029.

The consistent Thawing Equipment market report analyzes many points that help businesses to solve the toughest questions in less time. The major topics of this business report are global growth trends, market share by manufacturers, market size by type, market size by application, production by region, consumption by region, company profiles, market forecast, value chain and sales channels analysis, opportunities & challenges, threat and affecting factors. The report gives market definition in the form of market driving factors and market restraints which helps estimating the demand of particular product depending on several aspects. Thawing Equipment market survey report studies the global market status and forecast, categorizes the global market size, market value & market volume by key players, type, application, and region.

Key Players

Thermo Fisher Scientific Inc. (U.S.)

Merck KGaA (Germany)

ThermoGenesis Holdings Inc. (U.S.)

BioLifeSolutions (U.S.)

So-Low Environmental Equipment Co. (U.S.)

Helmer Scientific Inc. (U.S.)

OPS Diagnostics LLC (U.S.)

Sartorius AG (Germany)

Sarstedt AG & Co. KG (Germany)

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-thawing-equipment-market

One of the principal objectives of a high-ranking Thawing Equipment industry report is to analyze and study the global sales, value, status, and forecast. The market report also analyzes the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. The report assists to define, describe and forecast the market by type, application and region. It estimates the region that is foretold to create the most number of opportunities in the global Thawing Equipment market. This market research report comprises of estimations of CAGR values which are quite significant and aids businesses to decide upon the investment value over the time period. An insightful Thawing Equipment market report assists clients to stay ahead of the time and competition.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Thawing Equipment Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Sizing

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[healthcare-domain]

Drivers, Restraints, Industry-Specific Challenges, Opportunities, and Trends Affecting the Growth of Thawing System Market

The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices.

The global thawing system market is segmented by type, sample type, end user, and region. By type, the thawing system market is segmented into manual and automated devices. The manual devices segment is estimated to account for the largest market share of the global thawing system market in 2017. Factors driving the growth of this segment include the widespread use of manual devices and their low costs.

By sample type, the market is classified into blood, embryo, ovum, semen, and other samples. The blood segment is estimated to account for the largest share of the global thawing system market. The large share of this segment can be attributed to the increasing demand of blood and blood products and rising incidence of chronic diseases around the globe.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185341188

On the basis of end user, the thawing system market is segmented into blood banks and transfusion centers; hospitals and diagnostics laboratories; cord blood and stem cell banks; research and academic institutes; biotechnology and pharmaceutical companies; and tissue banks. The blood banks and transfusion centers segment is estimated to account for the largest share of the global thawing system market.  

The global thawing system market is dominated by North America, followed by Europe. North America will continue to dominate the global thawing system market in the forecast period. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered in Japan, China, and India. Factors such as rising focus of major players in emerging Asian countries and government support are driving the growth of the thawing system market in this region.

The factors such as the high degree of consolidation, high cost of devices, and complex regulatory framework for the approval of new products may restrain the market’s growth to a certain extent.

Major industry players launched innovative products to maintain and improve their position in the thawing system market. Helmer Scientific (US), Sarstedt (Germany), Sartorius (Germany), BioCision (US), and Boekel Scientific (US) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

[rishabh3210blog]

Global Fetal Bovine Serum Market Size, Growth Analysis Report, Forecast to 2021-2027

The global fetal bovine serum market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The factors contributing to the growth of the market include the rising consumption of fetal bovine serum in various applications and industries such as pharmaceutical & biotechnology and increasing academic research globally. Besides, to generate more revenue and expanding the market the key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/fetal-bovine-serum-market

For instance, in March 2021, Thermo Fisher Scientific Inc, has launched the new Gibco Human Plasma-like Medium (HPLM) which provides a realistic view of cell growth within the human body.  It is the first-ever cell culture medium that tends to mimic the metabolic profile of the human plasma. The HPLM provides researchers with the ability to study the impact of physiologically relevant cell media on their specific research applications which include cancer and other diseases. In the supplementation with fetal bovine serum, cell growth and viability can be achieved by HPLM. The new launch adds Thermo Fisher Scientific Inc to remain competitive in the fetal bovine serum market by expanding its product offering.

A Full Report of Global Fetal Bovine Serum Market is Available at: https://www.omrglobal.com/industry-reports/fetal-bovine-serum-market

Moreover, in December 2019, Sartorius AG acquired 50% shares of the Israeli cell culture media manufacturer and developer Biological Industries Ltd. for approximately $54 million in cash. Biological has specialization in cell culture media ad gene therapy. With this acquisition, Sartorius had expanded its business in the cell cultural media segment by offering a broad range of products that drives the market growth. Additionally, the acquisition helped Sartorius to remain competitive in the dynamically growing company in the field of life science and biotechnology. Considering these activities, significant growth can be expected in the market during the forecast period.

Global Fetal Bovine Serum Market Report Segment

By Product Type

Charcoal Stripped

Chromatographic

Dialyzed FBS

Stem Cell

Others (Exosome Depleted)

By End-User

Bioproduct & Pharmaceutical Company

Research Laboratory

Academic Institute

Others (Cell Bank)

By Application

Industrial Research

Scientific Research

Global Fetal Bovine Serum Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of the Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/fetal-bovine-serum-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

[riyaus]

Biological Safety Testing Products and Services Market Overview 2021

Biological Safety Testing Products and Services Market 2021

Biological safety testing is conducted to ensure that biopharmaceutical products such as therapeutics, drugs, blood, and blood-derived products, vaccines, stem cells, and tissue banks are contamination-free. The biological safety testing products include a set of assays using preclinical and clinical vector products. These products must undergo preclinical testing reviewed by the Food and Drug Administration (FDA) to ensure optimum safety.

The Biological Safety Testing Products and Services market size was valued at USD 2.93 billion in 2019 and is anticipated to grow with a CAGR of 12.29%.

Get a  Sample copy of this report : https://straitsresearch.com/report/Biological Safety Testing Products and Services-Market/request-sample

The Major Manufacturers Covered in this Report:

Charles River Laboratories, Lonza Group, MilliporeSigma, Merck, Sartorius Stedim, BioOutsource Limited and more...

[healthcaremarkettrend]

Cell Expansion Market: Ethical Concerns Regarding Research in Cell Biology

The Cell Expansion Market size is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.

Growth in this market is primarily driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.

The media segment accounted for the largest share of the consumables segment in the cell expansion market

Based on product type, consumables are segmented into media, reagents, sera, and disposables. The media segment accounted for the largest share of the consumables segment in the cell expansion market. The large share of this segment can be attributed to its high requirement during the production of pharmaceutical products and rising R&D investments on cell-based therapies.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

Biotechnology & biopharmaceutical companies accounted for the fastest-growing end user segment of the cell expansion market

Based on end-users, the cell expansion industry market has been segmented into research institutes, biotechnology & biopharmaceutical companies, cell banks, and other end users (includes hospitals, diagnostic centers, and laboratories). In 2019, biotechnology & biopharmaceutical companies were the largest end-users in the cell expansion market, and the trend is the same throughout the forecast period.

North America accounted for the largest share of the cell expansion market

North America accounted for the largest share of the cell expansion industry market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, increasing geriatric population, and the strong presence of industry players in the region.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883

Leading Companies

Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany)

[ourdimitriblr]

Cell Culture Market (covid-19 update) Upcoming Business Reports on Size, Shares, Stocks and Many More | Forecasting Report 2026

A New Research on the Cell Culture Market as conducted across a variety of industries in various regions to produce effective and useful reports. This study is a perfect blend of qualitative and quantitative information that highlights key market developments, gap analysis of industry and competitors, and challenges to new opportunities, and can trend in the market.

The Global Cell Culture Market Report was produced through extensive primary and secondary studies. The report also focuses on qualitative and quantitative assessments by analyzing data collected from industry analysts and market participants across key points in the industry's value chain, growth aspects, utilization and manufacturing capabilities.

Click HERE To get SAMPLE PDF (Including TOC, Table & Figures) at https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cell-culture-market

Significant Key Market Competitors of this Global Cell Culture Market –

Thermo Fisher Scientific, BD, GENERAL ELECTRIC, Merck KGaA, Lonza, HiMedia Laboratories, FUJIFILM Irvine Scientific, Miltenyi Biotec, InvivoGen, Danaher, Eppendorf AG, CellGenix GmbH, Corning Incorporated, Sartorius AG, PromoCell GmbH, VWR International LLC, Illumina Inc., Novogene Corporation, Geneious, Advanced BioMatrix, Inc., DWK Life Sciences, SciGenom Labs Pvt. Ltd, New England Biolabs, F. Hoffmann-La Roche Ltd, Cell Culture Technologies, QIAGEN, Agilent Technologies, Inc. and Bio-Rad Laboratories, Inc. among others.

Highlights of the Cell Culture Market Report:

Exact market size and CAGR forecasts for the period 2019-2026.

Identification and in-depth assessment of development opportunities in key segments and regions.

Complete company profiling of top players of the Cell Culture market.

Exhaustive research on innovation and other trends of the Cell Culture market

Consistent industry value chain and supply chain analysis

Complete examination of key growth drivers, restraints, challenges and development prospects.

Global Cell Culture Market Segmentation –

Product is Divided Into:

Consumables

Equipment

Applications is Divided Into:

Biopharmaceutical Production

Diagnostics

Drug Screening and Development

Stem Cell Research

Tissue Engineering & Regenerative Medicine

Other Applications

End User is Divided Into:

Pharmaceutical & Biotechnology Companies

Hospitals and Diagnostic Laboratories

Research Institutes

Cell Banks

Browse TOC with Selected illustrations and example pages of Global Cell Culture Market @ https://www.databridgemarketresearch.com/toc/?dbmr=global-cell-culture-market

Regional Analysis for Cell Culture Market:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

The Cell Culture Market provided all measurable data with clear data in the report. Clear data on financial dynamics, business ups and downs, product demands – supply chain, product sales, global market statistics, and market growth accelerators is eloquent. Descriptions of past, present, and future trends, along with various competitive factors and limitations, show how these factors affect Cell Culture Market development.

Browse Full Report @ https://www.databridgemarketresearch.com/reports/global-cell-culture-market    

Motivations To Buy :-

The conveyed report is accumulated using an energetic and concentrated investigation procedure

A complete picture of the significant circumstance of "Cell Culture" promote is depicted by this report.

The report contains an immense proportion of data about the continuous thing and inventive headways in the business areas.

It similarly gives an absolute evaluation of the ordinary lead about the future market and changing business division circumstance.

Settling on an informed business decision is a troublesome assignment; this report offers a couple of indispensable business methods to help you in choosing those choices.

To research the overall key areas advance potential and upheld position, opportunity and challenge, limitations and risks.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Browse Related Report:

Healthcare Additive Manufacturing Market

Hemoglobin Testing Market